ID: 1035 Transplantation of umbilical cord blood-derived mesenchymal stem cells to treat liver cirrhosis in mice: a comparison of tail and portal vein injection
DOI:
https://doi.org/10.15419/bmrat.v4iS.311Keywords:
liver disease, liver fibrosis, Mesenchymal stem cell, Regenerative Medicine, stem cell, umbilical cord blood stem cellAbstract
Background: Up to date, there have been some studies indicating positive effects of stem cells on treating the liver cirrhosis. In this study, we compared the effectiveness of two methods in which mesenchymal stem cells harvested from umbilical cord blood (UCB-MSCs) were transfused either via portal or tail veins to the mouse models of liver cirrhosis.
Methods: Liver cirrhosis was induced by CCl4 (1 ml/kg) on male Swiss mice within 11 weeks, followed by administration of 106 UCB-MSCs via the portal or tail vein. After 21 days, blood samples were collected for measuring transaminase, bilirubin and albumin activities. The expression of fibrosis-associated genes, specifically procollagen – alpha 1 and integrin – beta1, were assessed using qRT-PCR. The histopathology was also evaluated using hematoxylin/eosin, Masson trichrome staining and immunohistochemistry with collagen type 1 and alpha-SMA antibody.
Results: UCB-MSCs transplantation significantly improved post-21 days of treatment in the liver fibrosis mice as compared with placebo group. Notably, UCB-MSCs transferred through portal veins revealed a more positive effect than via tail veins as indicated by the improvement in the biochemical indexes, fibrosis-related genes expression, and liver histopathology.
Conclusion: The UCB-MSCs therapy proved to be a promising method for treating the liver cirrhosis. The method of delivering stem cells through portal vein was more effective than through tail vein
References
2. Zhong, Y., Tang, Z., Xu, R., Lin, N., Deng, M., Fang, H., Lin, J., Zhu, K., Liu, Y., and Kang, Z. (2013). Effect of transplantation route on stem cell migration to fibrotic liver of rats via cellular magnetic resonance imaging. Cytotherapy 15, 1266-1274.
3. Truong, N.H., Nguyen, N.H., Le, T.V., Vu, N.B., Huynh, N., Nguyen, T.V., Le, H.M., Phan, N.K., and Pham, P.V. (2016). Comparison of the Treatment Efficiency of Bone Marrow-Derived Mesenchymal Stem Cell Transplantation via Tail and Portal Veins in CCl4-Induced Mouse Liver Fibrosis. Stem Cells International 2016, 13.
4. Xue, H.L., Zeng, W.Z., Wu, X.L., Jiang, M.D., Zheng, S.M., Zhang, Y., and Li, H.Y. (2015). Clinical therapeutic effects of human umbilical cord-derived mesenchymal stem cells transplantation in the treatment of end-stage liver disease. Transplantation proceedings 47, 412-418.
5. Xue, G., Han, X., Ma, X., Wu, H., Qin, Y., Liu, J., Hu, Y., Hong, Y., and Hou, Y. (2016). Effect of Microenvironment on Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Hepatocytes In Vitro and In Vivo. BioMed research international 2016, 8916534.
Downloads
Published
Issue
Section
License
Copyright The Author(s) 2017. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
